Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.
Saved in:
| Title: | Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer. |
|---|---|
| Authors: | Sheng T; Department of Biochemistry, National University of Singapore, Singapore, 117596, Singapore.; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, 169857, Singapore., Ho SWT; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, 169857, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore., Ooi WF; Epigenetic and Epitranscriptomic Regulation, Genome Institute of Singapore, Singapore, 138672, Singapore., Xu C; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, 169857, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore., Xing M; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, 169857, Singapore.; Epigenetic and Epitranscriptomic Regulation, Genome Institute of Singapore, Singapore, 138672, Singapore., Padmanabhan N; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, 169857, Singapore., Huang KK; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, 169857, Singapore., Ma L; The Institute for Genomics and Systems Biology, The University of Chicago, Chicago, Illinois, USA., Ray M; The Institute for Genomics and Systems Biology, The University of Chicago, Chicago, Illinois, USA., Guo YA; Precision Medicine and Population Genomics (Somatic), Genome Institute of Singapore, Singapore, 138672, Singapore., Sim NL; Precision Medicine and Population Genomics (Somatic), Genome Institute of Singapore, Singapore, 138672, Singapore., Anene-Nzelu CG; Cardiovascular Research Institute, National University Health System, Singapore, 119074, Singapore.; Precision Medicine and Population Genomics (Germline), Genome Institute of Singapore, Singapore, Singapore.; Montreal Heart Institute, Montreal, Canada.; Department of Medicine, University of Montreal, Montreal, Canada., Chang MM; Precision Medicine and Population Genomics (Somatic), Genome Institute of Singapore, Singapore, 138672, Singapore., Razavi-Mohseni M; Department of Biomedical Engineering and McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University, Baltimore, USA., Beer MA; Department of Biomedical Engineering and McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University, Baltimore, USA., Foo RSY; Cardiovascular Research Institute, National University Health System, Singapore, 119074, Singapore.; Precision Medicine and Population Genomics (Germline), Genome Institute of Singapore, Singapore, Singapore., Sundar R; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, 169857, Singapore.; Department of Haematology-Oncology, National University Cancer Institute Singapore, National University Hospital, Singapore, 119074, Singapore., Chan YH; Biostatistics Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Singapore., Tan ALK; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, 169857, Singapore., Ong X; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, 169857, Singapore., Skanderup AJ; Precision Medicine and Population Genomics (Somatic), Genome Institute of Singapore, Singapore, 138672, Singapore., White KP; The Institute for Genomics and Systems Biology, The University of Chicago, Chicago, Illinois, USA. kevin@tempus.com.; Tempus Labs, Chicago, USA. kevin@tempus.com., Jha S; Department of Biochemistry, National University of Singapore, Singapore, 117596, Singapore. csisjha@nus.edu.sg.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore. csisjha@nus.edu.sg.; NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore. csisjha@nus.edu.sg.; Department of Physiological Sciences, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK, USA. csisjha@nus.edu.sg., Tan P; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, 169857, Singapore. gmstanp@duke-nus.edu.sg.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore. gmstanp@duke-nus.edu.sg.; Epigenetic and Epitranscriptomic Regulation, Genome Institute of Singapore, Singapore, 138672, Singapore. gmstanp@duke-nus.edu.sg.; SingHealth/Duke-NUS Institute of Precision Medicine, National Heart Centre Singapore, Singapore, 168752, Singapore. gmstanp@duke-nus.edu.sg.; Department of Physiology, National University of Singapore, Singapore, 117593, Singapore. gmstanp@duke-nus.edu.sg.; Singapore Gastric Cancer Consortium, Singapore, 119228, Singapore. gmstanp@duke-nus.edu.sg. |
| Source: | Genome medicine [Genome Med] 2021 Oct 11; Vol. 13 (1), pp. 158. Date of Electronic Publication: 2021 Oct 11. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101475844 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-994X (Electronic) Linking ISSN: 1756994X NLM ISO Abbreviation: Genome Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
